Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: 2 - The Untold Story

Operation Sindoor: What’s the significance of India’s Pakistan targets?

India struck multiple targets in Pakistan and Pakistan-administered Kashmir in the aftermath of the Pahalgam attack.

Al Jazeera

Earnings Preview: What to Expect From Humana's Report

Humana is expected to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit rise.

Barchart

Is Humana Stock Underperforming the Nasdaq?

Although Humana has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

MarketBeat

Humana Stock: Is Wall Street Bullish or Bearish?

Humana has underperformed the broader market by a large margin over the past year and analysts remain cautiously bullish on the stock’s prospects.

Barchart

Humana's Quarterly Earnings Preview: What You Need to Know

Humana is set to release its fourth-quarter results later this month, with analysts anticipating a significant drop in earnings.

Barchart

Is Humana Stock Underperforming the S&P 500?

Humana has substantially underperformed the S&P 500 over the past year and analysts remain cautiously bullish on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Humana Stock: Analyst Estimates & Ratings

Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.

Barchart

The Listeners on BBC One review: Rebecca Hall is a revelation as a woman pushed to the brink by 'the Hum'

4/5 This horror-inflected four-parter is a hallucinatory, nightmarish drama exploring mystery and conspiracy

Evening Standard

‘It brought me to my knees’: The Hum – a mysterious phenomenon that’s baffled the world for decades

IN FOCUS: It’s thought that 4 per cent of the global population is plagued by a persistent, rumbling sound in their ears – the source of which is a total enigma. Ellie Harrison speaks to the people who’ve been trying to get to the bottom of a noise that has…

The Independent UK

Humana's Q3 2024 Earnings: What to Expect

Humana is expected to release its fiscal third-quarter earnings this month, and analysts project a double-digit profit decline.

Barchart

Humana Stock Sinks on Weak Medicare Star Ratings: What to Know

Humana stock is spiraling Wednesday after the CMS provided preliminary Star Ratings data for the insurer's 2025 Medicare Advantage plans.

Kiplinger

How Is Humana's Stock Performance Compared to Other Healthcare Stocks?

Humana underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Humana Stock?

Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Is Centene's Stock Performance Compared to Other Healthcare Stocks?

Centene has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.

Barchart

Humana Stock: Is HUM Outperforming the Healthcare Sector?

Humana has recently outperformed the Healthcare sector, and Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart

Is HCA Healthcare Stock Outperforming the Dow?

HCA Healthcare has consistently surpassed the Dow Jones Industrial Average, and analysts are highly optimistic about its prospects.

Barchart

Is Elevance Health Stock Outperforming the S&P 500?

Elevance Health has outperformed the S&P 500 this year, and analysts remain optimistic about the stock's prospects due to its strong market presence and robust financial performance.

Get all your
news in one place.

100's of premium titles.
One news app.

Metal Hammer

"Thumps to the back of the head are tempered by prog, synths, sax and slowcore." Doom champions Pallbearer branch out on emotionally devastating new album Mind Burns Alive

After dipping their toes in the prog pool with 2020's Forgotten Days, Arkansas doom-mongers Pallbearer embrace experimental sounds with new album Mind Burns Alive

StockNews.com

3 Buy-Worthy Medical Stocks to Watch

The healthcare industry is well-positioned to thrive against most market adversities due to the perennial necessity and surging demand for healthcare services. Given this backdrop, let’s look at buy-worthy health insurance stocks UnitedHealth Group Incorporated (UNH), Humana Inc. (HUM), and Centene Corporation (CNC), which could be solid additions to your…

Evening Standard

Best supplements and herbal remedies for soothing anxiety

Leave all your worries behind

StockNews.com

3 Medical Stock Winners to Buy

The medical industry is positioned for growth due to rising healthcare costs, increased chronic diseases, and growing demand for quality healthcare. To that end, it could be wise to add fundamentally strong medical stocks Humana (HUM), Molina Healthcare (MOH), and Centene (CNC). Read more….

StockNews.com

3 Medical Stocks on Every Investors Watchlist

The health insurance industry is well-positioned for growth thanks to the rising healthcare costs, the prevalence of chronic diseases, and the growing demand for quality healthcare. To that end, it could be wise to add fundamentally strong medical stocks UnitedHealth Group (UNH), Humana (HUM), and Molina Healthcare (MOH) to one’s…

StockNews.com

1 Health Insurance Stock to Buy, 1 to Hold, and 1 to Sell

As healthcare costs rise, the demand for health insurance is expected to increase. Therefore, it could be wise to invest in Humana Inc. (HUM) and hold Bright Health Group (BHG) to look for a better entry point. However, avoiding the fundamentally weak stock Marpai, Inc. (MRAI) could be wise. Read…

StockNews.com

A Look Into Clover Health (CLOV) and Humana (HUM): Are They Worth Investing In?

The medical industry thrives due to rising demand for healthcare products and services, fueling significant growth. Therefore, quality medical stock Humana (HUM) could be worth buying. However, considering its weak fundamentals, I think it will be best to wait for a better entry point in Clover Health Investments (CLOV). Read…

1 2 3 4 5

People

Claire

855 stories

Dipanjan BanchurSince

Ahmed Sharif Chaudhry

19 stories

Jordan Tannahill

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UnitedHealth Group Incorporated

54 stories

Centene Corporation

51 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.